Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIOngoingJun 7, 2023Lidocaine 2.5% & Prilocaine 2.5% CreamCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0821-2023Class IIOngoingJun 7, 2023Levofloxacin Ophthalmic SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0820-2023Class IIOngoingJun 7, 2023Levofloxacin Oral SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0819-2023Class IIOngoingJun 7, 2023Levofloxacin Injection 500mg/20 mLCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0818-2023Class IIOngoingJun 7, 2023Levocarnitine Oral SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0817-2023Class IIOngoingJun 7, 2023Levetiracetam Oral Solution 100 mg/mLCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0816-2023Class IIOngoingJun 7, 2023Lactulose SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0815-2023Class IIOngoingJun 7, 2023Lactulose SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0814-2023Class IIOngoingJun 7, 2023Ketorolac Tromethamine Ophthalmic SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0813-2023Class IIOngoingJun 7, 2023IC-GreenCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0812-2023Class IIOngoingJun 7, 2023Hydromorphone Hydrochloride InjectionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0811-2023Class IIOngoingJun 7, 2023Hydrocortisone and Acetic Acid Otic SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0810-2023Class IIOngoingJun 7, 2023HydrALAZINE HCl InjectionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0809-2023Class IIOngoingJun 7, 2023Guaifenesin Oral SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0808-2023Class IIOngoingJun 7, 2023Guaiatussin AC Sugar-FreeCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0807-2023Class IIOngoingJun 7, 2023Granisetron HCl InjectionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0806-2023Class IIOngoingJun 7, 2023Gonak Hypromellose Ophthalmic Solution 25mg/mLCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0805-2023Class IIOngoingJun 7, 2023Fluticasone Propionate Nasal SprayCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0804-2023Class IIOngoingJun 7, 2023Ferrous Sulfate Iron Supplement DropsCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0803-2023Class IIOngoingJun 7, 2023Ephedrine Sulfate InjectionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0802-2023Class IIOngoingJun 7, 2023DOCU LIQUIDCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0801-2023Class IIOngoingJun 7, 2023Diuril (chlorothiazide sodium) InjectionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0800-2023Class IIOngoingJun 7, 2023Dicyclomine Hydrochloride Injection USPCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0799-2023Class IIOngoingJun 7, 2023DetomiSedCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0798-2023Class IIOngoingJun 7, 2023Cromolyn Sodium Ophthalmic SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0797-2023Class IIOngoingJun 7, 2023Clobetasol Propionate ShampooCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0796-2023Class IIOngoingJun 7, 2023Clobetasol Propionate OintmentCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0795-2023Class IIOngoingJun 7, 2023Clobetasol Propionate CreamCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0794-2023Class IIOngoingJun 7, 2023Cimetidine HCl Oral Solution 300mg/5mLCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0793-2023Class IIOngoingJun 7, 2023Ciclopirox Topical Solution 8%CGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0792-2023Class IIOngoingJun 7, 2023Cetrorelix Acetate for InjectionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0791-2023Class IIOngoingJun 7, 2023Calcitriol Injection 1 mcg/mLCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0790-2023Class IIOngoingJun 7, 2023Calcipotriene Topical SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0789-2023Class IIOngoingJun 7, 2023AK-POLY-BACCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0788-2023Class IIOngoingJun 7, 2023Azelastine Hydrochloride Nasal SprayCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0787-2023Class IIOngoingJun 7, 2023Artificial Tears OintmentCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0786-2023Class IIOngoingJun 7, 2023Artificial Tears SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0785-2023Class IIOngoingJun 7, 2023Apraclonidine Ophthalmic Solution 0.5%CGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0784-2023Class IIOngoingJun 7, 2023Albuterol Sulfate SyrupCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0783-2023Class IIOngoingJun 7, 2023Acyclovir Oral SuspensionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0782-2023

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.